XYL
37
2
KR
34
-3
JNPR
46
3
HUM
48
6
ED
48
3
ORLY
53
-3
ETR
68
3
AMGN
44
5
NWL
44
-4
NOV
58
3
TDC
75
4
EXR
57
-2
QCOM
48
-7
V
60
-6
CL
56
5
DVN
16
3
UNH
61
6
OXY
40
3
NWS
62
-2
MRK
22
3
XYL
37
2
KR
34
-3
JNPR
46
3
HUM
48
6
ED
48
3
ORLY
53
-3
ETR
68
3
AMGN
44
5
NWL
44
-4
NOV
58
3
TDC
75
4
EXR
57
-2
QCOM
48
-7
V
60
-6
CL
56
5
DVN
16
3
UNH
61
6
OXY
40
3
NWS
62
-2
MRK
22
3
Financhill
Back

Exicure Vs. Perspective Therapeutics Industry Stock Comparison

Sell
25

XCUR
Exicure

Last Price:
10.11
Seasonality Move:
-3.8%
Sell
30

CATX
Perspective Therapeutics

Last Price:
3.99
Seasonality Move:
40.67%
Sell
25
Exicure (XCUR) is a Sell

Is Exicure a Buy, Sell or Hold?

  • The current Exicure [XCUR] share price is $11.19. The Score for XCUR is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
  • XCUR is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
30
Perspective Therapeutics (CATX) is a Sell

Is Perspective Therapeutics a Buy, Sell or Hold?

  • The current Perspective Therapeutics [CATX] share price is $6.17. The Score for CATX is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • CATX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

XCUR Stock Price Chart

What is Exicure's stock price today?

  • The Exicure share price today is $11.19
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and XCUR is experiencing slight buying pressure.

CATX Stock Price Chart

What is Perspective Therapeutics's stock price today?

  • The Perspective Therapeutics share price today is $6.17
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CATX is experiencing selling pressure, which indicates risk of future bearish movement.

XCUR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.96 Buy
Relative Strength Index (14 RSI): 88.64 Buy
Chaikin Money Flow: 2149852 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.5 - 5.02) Buy
Bollinger Bands (100): (1.41 - 3.69) Buy

CATX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.47 Sell
Relative Strength Index (14 RSI): 14.63 Sell
Chaikin Money Flow: -723713 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (8.98 - 12.88) Sell
Bollinger Bands (100): (10.81 - 14.53) Sell

XCUR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 4.51 Buy
20-day SMA: 3.41 Buy
50-day SMA: 3.08 Buy
200-day SMA: 2.6 Buy
8-day EMA: 5.4 Buy
20-day EMA: 3.97 Buy
50-day EMA: 3.19 Buy
200-day EMA: 2.98 Buy

CATX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 8.55 Sell
20-day SMA: 10.54 Sell
50-day SMA: 12.08 Sell
200-day SMA: 12.78 Sell
8-day EMA: 8.2 Sell
20-day EMA: 9.96 Sell
50-day EMA: 11.52 Sell
200-day EMA: 11.52 Sell

Exicure Earnings Growth & XCUR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Perspective Therapeutics Earnings Growth & CATX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.78 per share, and a decrease next year of $0.49 per share.

Exicure Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Perspective Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):